Original Contributions |
From Institut National de la Santé et de la Recherche Médicale (INSERM) U321, Pavillon Benjamin Delessert, Hôpital de la Pitié (L.C., F.N., M.J.C.), Laboratoire de Biochimie "B," Hôpital de la Salpêtrière (S.L.), and Institut Fédératif de Recherche de Physiopathologie et de Génétique Cardiovasculaire, Centre Hospitalo-Universitaire de la Pitié-Salpêtrière (L.C., F.N., S.L., M.J.C.), Paris; and INSERM U347 (P.T., M.C.) and Laboratoire de Biochimie (P.T.), Hôpital de Bicêtre, Bicêtre, France.
Correspondence to Dr M.J. Chapman, INSERM U321, Hôpital de la Pitié, 75651 Paris Cédex 13, France.
AbstractAbundant evidence has
been provided to substantiate the elevated
cardiovascular risk associated with small, dense, low
density lipoprotein (LDL) particles. The diminished resistance of dense
LDL to oxidative stress in both normolipidemic and
dyslipidemic subjects is established; nonetheless, the
molecular basis of this phenomenon remains indeterminate. We have
defined the primary molecular targets of lipid hydroperoxide formation
in light, intermediate, and dense subclasses of LDL after
copper-mediated oxidation and have compared the relative stabilities of
the hydroperoxide derivatives of phospholipids and cholesteryl esters
(CEs) as a function of the time course of oxidation. LDL subclasses
(LDL1 through LDL5) were isolated from normolipidemic plasma by
isopycnic density gradient ultracentrifugation, and
their content of polyunsaturated molecular species of
phosphatidylcholine (PC) and CE and of lipophilic antioxidants was
quantified by reverse-phase high-performance liquid
chromatography. The molar ratio of the particle content
of polyunsaturated CE and PC species containing linoleate or
arachidonate relative to
-tocopherol or
ß-carotene did not differ significantly between LDL subspecies.
Nonetheless, dense LDL contained significantly less polyunsaturated CE
species (400 mol per particle) compared with LDL1 through LDL4 (range,
680 to 490 mol per particle). Although the formation of PC-derived
hydroperoxides did not vary significantly between LDL subspecies as a
function of the time course of copper-mediated oxidation, the abundance
of the C18:2 and C20:4 CE hydroperoxides was uniquely deficient in
dense LDL (23 and 0.6 mol per particle, respectively, in LDL5; 47 to 58
and 1.9 to 2.3 mol per particle, respectively, in other LDL subclasses)
at propagation half-time. When expressed as a lability ratio (mol
hydroperoxides formed relative to each 100 mol of substrate consumed)
at half-time, the oxidative lability of CE hydroperoxides in dense LDL
was significantly elevated (lability ratio <25:100) relative to that
in lighter, larger LDL particle subclasses (lability ratio >40:100)
throughout the oxidative time course. We conclude that the elevated
lability of CE hydroperoxides in dense LDL underlies the diminished
oxidative resistance of these particles. Moreover, this phenomenon
appears to result not only from the significantly elevated PC to free
cholesterol ratio (1.54:1) in dense LDL particles (1.15:1
to 1.25:1 for other LDL subclasses) but also from their unique
structural features, including a distinct apoB100 conformation, which
may facilitate covalent bond formation between oxidized CE and apoB100.
Key Words: LDL subclasses reversed-phase high-performance liquid chromatography lipophilic antioxidants cholesteryl ester hydroperoxides polyunsaturated fatty acids
This article has been cited by other articles:
![]() |
G. Catalano, E. Duchene, Z. Julia, W. Le Goff, E. Bruckert, M. J. Chapman, and M. Guerin Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects J. Lipid Res., March 1, 2008; 49(3): 635 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-h. Chen, B. D. Hosken, M. Huang, J. W. Gaubatz, C. L. Myers, R. D. Macfarlane, H. J. Pownall, and C.-y. Yang Electronegative LDLs from familial hypercholesterolemic patients are physicochemically heterogeneous but uniformly proapoptotic J. Lipid Res., January 1, 2007; 48(1): 177 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gazi, E. S. Lourida, T. Filippatos, V. Tsimihodimos, M. Elisaf, and A. D. Tselepis Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Small, Dense LDL Particles in Human Plasma Clin. Chem., December 1, 2005; 51(12): 2264 - 2273. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hansel, P. Giral, E. Nobecourt, S. Chantepie, E. Bruckert, M. J. Chapman, and A. Kontush Metabolic Syndrome Is Associated with Elevated Oxidative Stress and Dysfunctional Dense High-Density Lipoprotein Particles Displaying Impaired Antioxidative Activity J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4963 - 4971. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pavan, A. Hermouet, V. Tsatsaris, P. Therond, T. Sawamura, D. Evain-Brion, and T. Fournier Lipids from Oxidized Low-Density Lipoprotein Modulate Human Trophoblast Invasion: Involvement of Nuclear Liver X Receptors Endocrinology, October 1, 2004; 145(10): 4583 - 4591. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Teerlink, P. G. Scheffer, S. J. L. Bakker, and R. J. Heine Combined data from LDL composition and size measurement are compatible with a discoid particle shape J. Lipid Res., May 1, 2004; 45(5): 954 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Holvoet, S. B. Kritchevsky, R. P. Tracy, A. Mertens, S. M. Rubin, J. Butler, B. Goodpaster, and T. B. Harris The Metabolic Syndrome, Circulating Oxidized LDL, and Risk of Myocardial Infarction in Well-Functioning Elderly People in the Health, Aging, and Body Composition Cohort Diabetes, April 1, 2004; 53(4): 1068 - 1073. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kontush, E. C. de Faria, S. Chantepie, and M. J. Chapman Antioxidative Activity of HDL Particle Subspecies Is Impaired in Hyperalphalipoproteinemia: Relevance of Enzymatic and Physicochemical Properties Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 526 - 533. [Abstract] [Full Text] |
||||
![]() |
A. Kontush, S. Chantepie, and M. J. Chapman Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress Arterioscler. Thromb. Vasc. Biol., October 1, 2003; 23(10): 1881 - 1888. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Holvoet, T. B. Harris, R. P. Tracy, P. Verhamme, A. B. Newman, S. M. Rubin, E. M. Simonsick, L. H. Colbert, and S. B. Kritchevsky Association of High Coronary Heart Disease Risk Status With Circulating Oxidized LDL in the Well-Functioning Elderly: Findings From the Health, Aging, and Body Composition Study Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1444 - 1448. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Williams, H. R. Superko, W. L. Haskell, E. L. Alderman, P. J. Blanche, L. G. Holl, and R. M. Krauss Smallest LDL Particles Are Most Strongly Related to Coronary Disease Progression in Men Arterioscler. Thromb. Vasc. Biol., February 14, 2003; 23(2): 314 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Sposito and M. J. Chapman Statin Therapy in Acute Coronary Syndromes: Mechanistic Insight Into Clinical Benefit Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1524 - 1534. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chancharme, P. Therond, F. Nigon, S. Zarev, A. Mallet, E. Bruckert, and M. J. Chapman LDL particle subclasses in hypercholesterolemia: molecular determinants of reduced lipid hydroperoxide stability J. Lipid Res., March 1, 2002; 43(3): 453 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Tsimihodimos, S.-A. P. Karabina, A. P. Tambaki, E. Bairaktari, G. Miltiadous, J. A. Goudevenos, M. A. Cariolou, M. J. Chapman, A. D. Tselepis, and M. Elisaf Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia J. Lipid Res., February 1, 2002; 43(2): 256 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lepage, F. Nigon, D. Bonnefont-Rousselot, U. Assogba, S. Goulinet, L. Chancharme, J. Delattre, E. Bruckert, and M. J. Chapman Oxidizability of Atherogenic Low-Density Lipoprotein Subspecies in Severe Familial Hypercholesterolemia: Impact of Long-Term Low-Density Lipoprotein Apheresis Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(2): 87 - 103. [Abstract] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |